Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin for Postoperative Crohn's Disease Recurrence
NCT00609973Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- May 2008
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ciprofloxacin in Crohn's disease, sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Safety and Tolerability of Ciprofloxacin at 6 months. Started May 2008; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00609973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00609973.